Dendritic Cells Pulsed with Peptides of GP63 Induce Differential Protection against Experimental Cutaneous Leishmaniasis
Authors:
- 1 September 2004
- journal article
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 17 (3) , 343-352
Abstract
The need for a vaccine against Leishmania spp., a major cause of worldwide morbidity and mortality, is urgent. We tested the efficacy of an experimental vaccination in murine models of cutaneous leishmaniasis, using dendritic cells (DCs) pulsed with synthetic or native parasite antigens. DCs pulsed with peptide 154–169aa of gp63 or soluble promastigote lysate (SPL) triggered antigen-specific immune responses and efficiently reduced lesion formation and parasite load of genetically susceptible BALB/c mice infected with Leishmania major. This effect was accompanied by a modulation of the cellular immune response towards a Th1 profile. Vaccination of genetically resistant CBA mice with DCs pulsed with peptide 154–169aa or SPL did not affect the course of the disease, whereas pulsing with the epitope 467–482aa of gp63 resulted in disease exacerbation, accompanied by a switch to a Th2 profile. In view of our continuously growing knowledge about the immunobiology of DCs, these findings suggest that vaccination with DCs pulsed with defined peptides could be a strategy against infectious diseases. Peptide selection is a prerequisite as they can differentially regulate the type of immune response in susceptible or resistant hosts.Keywords
This publication has 40 references indexed in Scilit:
- Dendritic Cell-Based Vaccination Strategies: Induction of Protective Immunity against LeishmaniasisImmunobiology, 2001
- Mini-ReviewDendritic cells as vectors for vaccination against infectious diseasesInternational Journal of Medical Microbiology, 2001
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Immunobiology of Dendritic CellsAnnual Review of Immunology, 2000
- Long-term protection of mice against Leishmania major with a synthetic peptide vaccineVaccine, 1999
- ISCOMs vaccine against experimental leishmaniasisVaccine, 1998
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Dendritic cells in Leishmania major‐immune mice harbor persistent parasites and mediate an antigen‐specific T cell immune responseEuropean Journal of Immunology, 1995
- Immunoprotective Leishmania major synthetic T cell epitopes.Journal of Experimental Medicine, 1990
- A limiting dilution assay for quantifying Leishmania major in tissues of infected miceParasite Immunology, 1985